Categories Earnings, Health Care

Allscripts (NASDAQ: MDRX): Q3 2019 Earnings Snapshot

— Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) reported its third-quarter 2019 adjusted earnings of $0.17 per share and GAAP loss of $0.03 per share. The results came in line with the analysts’ expectations.

— Revenue increased by 3% to $444 million and adjusted revenue rose by 1% to $445 million. This is compared to the consensus estimates of $450.16 million.

Earnings Update by AlphaStreet

— Bookings jumped by 19% to $236 million in the third quarter of 2019. Contract revenue backlog totaled $3.9 billion as of September 30, 2019.

— Looking ahead, the company expects revenue growth to improve as it benefits from the strategic investments across both its Provider and Veradigm businesses.

— For the full year 2019, the company narrowed its adjusted earnings guidance to the range of $0.67 to $0.70 per share from the previous range of $0.65 to $0.70 per share. The street’s view is $0.68 per share.

— Bookings are still anticipated to be in the range of $1.05 billion to $1.10 billion for the full year.

— Adjusted revenue outlook is reiterated in the range of $460 million to $470 million for the fourth quarter of 2019 versus the consensus estimates of $462.74 million.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Add Comment
Viewing Highlight